Exane BNP Paribas Downgrades Visteon to Neutral, Announces $130 Price Target
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas analyst James Picariello has downgraded Visteon (NASDAQ:VC) from Outperform to Neutral and set a price target of $130.

December 13, 2023 | 11:36 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Visteon downgraded by Exane BNP Paribas from Outperform to Neutral with a new price target of $130.
Downgrades typically lead to a negative perception among investors, potentially causing short-term price declines. However, the establishment of a price target at $130 may suggest that the current price is close to the analyst's perceived fair value, indicating a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100